Kewaunee Scientific appoints J. Jette Campbell to board of directors

Published 11/09/2025, 21:10
Kewaunee Scientific appoints J. Jette Campbell to board of directors

STATESVILLE, N.C. - Kewaunee Scientific Corporation (NASDAQ:KEQU) has appointed J. Jette Campbell, CPA, to its Board of Directors, effective September 10, 2025, according to a company statement released Thursday.

Campbell brings extensive experience from previous leadership roles at PepsiCo, Frito-Lay, and Griffin LLC, a DuPont venture. He also served as a partner at Carl Marks Advisors, working with clients across various industries.

David S. Rhind, Chairman of the Board, cited Campbell’s experience and knowledge of building materials and furniture manufacturing sectors as valuable additions to the company’s leadership team.

"Jette’s appointment adds an additional layer of strength to our Board at a time Kewaunee is focused on accelerating growth through both organic and inorganic means," said Thomas D. Hull III, President and Chief Executive Officer of Kewaunee. The company’s focus on growth is reflected in its strong financial performance, with revenue growing 18% over the last twelve months and maintaining a healthy gross margin of 29%. According to InvestingPro data, the company’s overall financial health score is rated as "GREAT."

Kewaunee Scientific, founded in 1906, designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company’s stock has shown strong momentum, delivering a 27% return over the past year, while maintaining solid liquidity with a current ratio of 2.2. Analysis from InvestingPro suggests the stock is currently undervalued. The company maintains its corporate headquarters in Statesville, North Carolina, with sales offices in the United States, India, Saudi Arabia, and Singapore. It operates three manufacturing facilities in Statesville and one in Bangalore, India.

The company recently acquired Nu Aire, a manufacturer of biological safety cabinets and other laboratory products, which has manufacturing facilities in Minnesota and partnerships in the Netherlands and China. InvestingPro subscribers can access additional insights, including 6 more ProTips and detailed financial metrics that provide a comprehensive view of Kewaunee’s growth strategy and market position.

In other recent news, Kewaunee Scientific Corporation reported fourth-quarter earnings that surpassed previous results. The company posted adjusted earnings per share of $1.95 for the quarter ending April 30, 2025, with revenue increasing by 36.1% year-over-year to $77.15 million. These strong financial results have drawn attention from investors, highlighting a period of significant growth for the company. Additionally, Kewaunee Scientific held its Annual Meeting of Shareholders, where Margaret B. Pyle and Donald F. Shaw were re-elected as Class III directors for three-year terms. Pyle received 1,633,067 votes in favor, while Shaw secured 1,730,171 votes. Both directors had 537,449 non-voting shares recorded. Shareholders also approved the appointment of the company’s auditor during the meeting. These developments reflect key actions and results for Kewaunee Scientific in recent times.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.